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Abstract 
Balloon expandable stents have been used to manage coarctation of the aorta in 
selected patients with very encouraging results. After the successful use of the 
Palmaz stents in these lesions newer stents as well as modifications of the Palmaz 
stents have been introduced to achieve optimal results in these patients. In this 
review, the older as well as the newer type stents used in coarctation are discussed. 
Technical considerations to achieve successful stent implantation and choice is 
outlined. 
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Balloon dilation has gained acceptance in the treatment of coarctation of the aorta 
both native and recurrent.1–6 A number of patients develop recoarctation after balloon 
angioplasty7–10 possibly as a result of elastic recoil or long segment stenosis. 
Additionally in order to achieve successful reduction in the gradient, over sizing of the 
balloon may be necessary with potential for complications. Stents provide radial 
strength to avoid recoil of the vessel , and a framework for endothelial growth.10 Over 
the last few years stents have been used in selected patients to treat coarctation of 
the aorta both native and recurrent with encouraging results.11–17 Limitations of 
existing stents were recognized. Desirable characteristics in the implantable stents 
would include flexibility, relatively small profile to allow introduction in children or 
small adults, ability to further dilate to adult size as the patient grows, high radial 
strength, non sharp edges, wide struts to uninhibit flow if covering a vessel and 
allowing access to the side branches if covered and ability to reposition if necessary. 
Significant improvement in the existing stent designs as well as introduction of new 
stents was accomplished in the recent years. The advancement in stent technology 
aimed at achieving some of these desirable characteristics. The following review 
discusses the most commonly used stents for coarctation and addresses some of the 
technical considerations. 
 
Stents 
After the initial success in treating iliac artery stenosis,18–20 stents were used to treat 
stenotic lesions associated with congenital heart disease21–23 both native and post 
operative and shortly thereafter were used in coarctation of the aorta.11–17 The most 
commonly used stent is the balloon dilatable type which allows for further expansion 
of the stent as the patient grows. Self expanding stents have been only infrequently 
used because of the limitation of further expansion and the limited radial strength.24,25 
The following are the stents commonly used for coarctation of the aorta. 
 
I-Palmaz Stents (Johnson & Johnson Interventional Systems Co., Warren, NJ) 
The Palmaz stents are balloon expandable stainless steal prostheses. They have a 
closed cell design which gives them high radial strength but makes them less flexible. 
Most of these stents are hand mounted and crimped on the delivery balloon. Until 
recently the large Palmaz stents (P308, 188) were the only ones available in the 
United States and considered suitable for coarctation of the aorta. The first 2 digits 
are the length of the stent in mms. The final digit represents the minimum 
recommended expanded diameter. This in turn reflects on the maximum diameter it 
can achieve and the radial strength. The wall thickness is .005 inch and the 
unexpanded diameter is 3.4 mm. All these factors influence the size of the balloon it 
can be crimped on as well as the minimum sheath size. These stents have a 
recommended expanded diameter between 8-12 mm but are commonly over dilated 
to 18-20 mm with some difficulty. A significant number of patients have had P308 
stents implanted in the coarctation site with excellent results12–16 (figure 1,2 Table I). 
However over dilation of these stents results in significant foreshortening < 33% at 12 
mm and up to 50% at 18 mm15 and is met with significant stent resistance. Smaller 
Palmaz stents (series ending with the digit 4) have been used sporadically under 
individual circumstances and are not generally used because of the limited 
expandability with growth. 
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Figure 1 A 30 year old lady with poorly controlled hypertension was diagnosed to 
have native coarctation (A). A Palmaz P 308 stent was placed as a primary 
intervention. Post stent, there was no residual angiographic narrowing (B) or 
significant gradient. On follow-up her lower extremity blood pressure was higher than 
her arm pressure as is generally seen in normal individuals. She has been taken off 
anti hypertension treatment and remains normotensive. 
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Figure 2 A 14 year old patient with recurrent coarctation after subclavian flap 
angioplasty. A transseptal approach (black arrow) was utilized to obtain accurate 
assessment of stent position prior to deployment to avoid the carotid artery. Notice 
accurate stent position in relation to the carotid. The systolic gradient decreased from 
35 to 4 mm.Hg. 
 
 
 
 
Table 1 Comparison of Genesis and Palmaz stents 
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Figure 3 A 15 year old referred with diagnosis of coarctation (A & B) and poorly 
controlled hypertension. Angiogram shows severe coarctation seen better on lateral 
view (A). A Palmaz P-3110 stent (C & D) was placed eliminating the gradient which 
was 53 mm Hg. 
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Figure 4 Recurrent coarctation involving a relatively long segment (A). A Palmaz P- 
4010 stent was used (B). The wire was placed in the right subclavian (B-D). Notice 
the use of BIB balloon. Inflation of the inner balloon (D) allows for initial expansion of 
the stent center followed by the outer balloon (E). After implantation there was 
excellent angiographic and hemodynamic result (F). 
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Figure 5 Lateral projection of patient described in Figure 4. Notice the multiple 
angiograms obtained using the transseptally placed left ventricular catheter allowing 
for fine adjustment of stent position prior to deployment. 
 
 
 
 
Table 2 Further comparison of Genesis and Palmaz stents 
 
 
 
Extra large diameter Palmaz stents 
These have became available in the United States and were designated P3110, 
3010, 4010, 5010, (4014, 5014 outside the US). The numbering implications are 
similar to the 8-series outlined earlier. The wall thickness is .013 in. These stents are 
expandable to 25 mm while maintaining their radial strength. Their foreshortening 
ranges between 2.5% at 10 mm and 23% at 25 mm (off label). The 3010 is available 
balloon mounted on 12 mm delivery balloon. The others are hand mounted on the 
selected balloons. These stents require relatively larger balloons for adequate hand 
crimping and larger sheaths than the series ending with 8. (figure 3-5, tables 1,2). 
They offer a significant advantage because of their expandability, radial strength and 
less fore shortening. 
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The Palmaz Genesis stent 
The Palmaz-Genesis stent (Cordis / Johnson and Johnson) was introduced to 
overcome some of the short falls of the Plamaz stents. It was designed to have lower 
profile, minimize shortening, add radial strength, and increase flexibility. It has a 
closed cell design based on the FlexSegemnt technology (Figure 6) which improves 
flexibility, reduces shortening and improves scaffolding in a bend. The original 
Genesis® stent was successful in negotiating tight curves and had good radial 
strength. However the maximum diameter which can be achieved is less than optimal 
for coarctation. Subsequently the Palmaz Genesis, large and extra large diameters 
(XD), were introduced to allow larger diameter expansion while retaining the 
favorable characteristics of the genesis stent. The Genesis XD is expandable off 
label to 18 mm in bench work while maintaining flexibility and excellent radial force. 
(Tables 1,2). It has equivalent or higher strength to the Palmaz P-308 stent with less 
shortening. Its application and expandability for coarctation remains to be tested in a 
large group of patients. 
 
Figure 6 Flex segment technology used in manufacturing the Palmaz Genesis 
stent:allows for better negotiation of curves while maintaining radial strength 
 
 
II-The Intrastent (IT) double strut® (Intratherapeutics, St. Paul, MN, recently 
acquired by ev3, Plymouth, MN) 
The IT LD stent was introduced in an attempt to improve on the only stent existing at 
that time considered suitable for coarctation (namely the Palmaz). This new stent has 
an open cell design composed of parallel struts of laser cut 316L stainless steel.26,27 
The unexpanded diameter is 3.8 mm length with no foreshortening at 12 mm 
diameter. The design allows for better flexibility and maneuverability. The 
maneuverability may be a significant advantage when placing the stent in tortuous 
areas through tight curves as the pulmonary arteries, though this is not necessarily 
the case in coarctation. The flexibility does, however, offer some possible advantage 
when implanted along the curve of the aortic arch. The initially introduced Intrastent 
(double strut LD) was tested in bench research up to 12 mms. against the Palmaz 
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stent, and was felt to have comparable radial strength. Expanding the stent beyond 
12 or 15 mms. has not been as encouraging as what initially was hoped. It was noted 
to have less radial strength,26,27 (and personal experience). Elastic recoil of the stent 
was noticed on deflation of the balloon in certain lesions requiring high radial 
strength. Additionally, distortion of the stent with either shortening or elongation has 
been recognized when larger diameters were attempted. This stent has not gained 
popularity in coarctation which may require diameter beyond 12-15 mms. The same 
company introduced two stents which are expandable to larger diameters while 
maintaining the integrity of the stent as well as the radial strength. The Mega LD® 
(unexpanded diameter 3.8 mm) and Max LD® (unexpanded diameter 4.5 mm) stents 
were introduced (series S17 and S18 respectively) in varying lengths (16, 26, 36 
mm). These stents can be expanded up to 18 and 25 mms., respectively, with < 25 
% shortening at the largest diameters. They also maintain good radial strength. 
These stents have the possible advantage of conforming to the curve of the aortic 
arch, (figures 7-9) while maintaining the radial strength as well as the advantage of 
open cell design especially if crossing a side branch. These however require slightly 
larger balloons and sheaths for adequate crimping and deployment because of their 
larger unexpanded diameter compared to the Palmaz stents (Series-8). 
 
 
 
 
 
 
Figure 713 year old with recurrent coarctation after end to end repair. A) shows initial 
coarctation appearance. B) post balloon angioplasty there was mild improvement. 
Intra-therapeutics (Max) stent was subsequently placed (C & D). Stent position was 
adjusted based on the LV angiogram. E) The gradient decreased from 35 mm Hg to 
1 mmHg after stent placement 
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Figure 8 Recurrent coarctation after subclavian flap aortoplasty (arrow). Note the 
proximity to the left carotid artery. Multiple LV angiograms obtained to accurately 
place the stent before and after uncovering the stent. The two ends of the balloon 
were allowed to expand slightly (C & D) with further imaging prior to fully deploying 
the stent (Max, IT Stent). 
 
 
Figure 9 Severe native coarctation in a 12 year old. Retrograde crossing was difficult 
because of the presence of dilated collaterals. A wire was passed from the brachial 
artery (B & C), snared from the groin thus establishing the accurate track prior to 
successful stent placement (D). The gradient decreased at implantation from 80 
mmHg to 25. Redilation was performed 9 months later. 
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III -Cheatham-Platinum (CP) Stent (NuMed, Hopkinton, NY) 
The CP stent was developed by NuMed (Hopkinton, New York), in collaboration with 
John Cheatham, MD, to provide improvement on the stents available at that time 
which was the Palmaz. This stent was made from heat-tempered 90% platinum and 
10% Iridium, .01 inch wire arranged in a zig pattern.16 The number of the zigs is 
variable between 6-8 per row and will affect the final diameter, profile and the 
strength of the stent as well as the percent shortening. If the target lesion expected 
diameter is < 15 mm then a 6 zig would be sufficient especially if it is in small child 
thus having a lower profile stent. The latter, however, would have limited application 
for coarctation because of the usually larger diameter required. The 8 zig / row 
configuration can be dilated up to 24 mm but has larger profile (28) and would offer a 
better choice for treating coarctation. A custom made 10 zig stent can be made and 
dilatable up to 30 mm with < 20 % shortening but would have a larger profile 
requiring larger sheath. Initial published results of this stent are encouraging.16 There 
was rare incidence of stent fatigue fracture. 
 
Technical tips for implantation 
This section is not intended to be a full discussion of the implantation technique, but 
rather to present a few tips reflecting personal preference and may or may not be 
applicable to every patient or operator. We, however, feel that these are helpful to 
achieve successful stent implantation. 
 1. Wire choice 
The wire is chosen to provide extra support (for example: extra stiff or super stiff 
wires) to avoid stent / balloon migration during implantation. We position the wire to 
ensure that the stiff part is well in the position of implantation and extends proximally 
as much as possible keeping the floppy end distant from the implantation site. This is 
accomplished by placing the tip of the wire in the right subclavian artery (or in the left 
subclavian, depending on the location of the coarctation) or occasionally by making a 
loop in the ascending aorta. (figures 2,4,5,7,8) 
 2. Complex arch anatomy 
In these patients, the position of the stent has to be very accurate to avoid 
unnecessary covering of the proximal branches or extension to distal aneurysms. We 
usually enter the left ventricle from prograde fashion, either using a transseptal 
puncture (figures 2,4,5,7,8) or through a PFO (figure 8) and place an angiographic 
catheter in the left ventricle to obtain angiograms and pressure measurements, 
before, during and after deployment. Multiple angiograms are obtained; before and 
after uncovering the stent with adjustment of stent position as necessary. 
 3. Stent choice 
The ideal stent is probably not available, but certain characteristics make some 
stents more attractive than others in different positions of the coarctation. The stent 
should be chosen that is expandable to an adult size aorta. A more flexible stent may 
be better suited if the implantation is across the arch (figures 7,8). If the stent may 
cover side branches or neck vessels, then an open cell design may be more 
attractive. 
 4. Balloon choice and inflation 
The perfect balloon would be of low profile, high pressure, have enough material to 
allow easy crimping of the stent and resistant to rupture. These facts are difficult to 
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achieve because a thin balloon would be more prone to rupture, and more difficult to 
accurately mount and crimp the stent. A larger material balloon will require a larger 
sheath. However the industry has achieved significant improvement in the balloon 
designs and material. Another consideration is the length of the balloon in relation to 
the stent i.e. shorter versus longer. Both offer some potential advantages and is 
interventionalist dependent. The shorter balloons offer the advantage of inflating the 
inner part of the stent first thus avoiding the potential complications of flaring of the 
ends of the stents resulting in balloon rupture or vessel wall perforation. However it 
can result in stent sliding or embolization making it difficult to accurately place the 
stent. The longer balloons allow more precise placement and repositioning if 
necessary before fully inflating the balloon. We generally use balloons slightly longer 
than the stent or the BIB balloon (NuMed, Hopkinton, NY), which offers two balloons, 
one shorter (inner) and one longer (outer) than the stent. When we use the longer 
balloon method and if precise positioning of the stent is required, we find it helpful to 
initially uncover only the distal part of the balloon (the end further from the operator). 
The balloon is slightly inflated, thus allowing the distal part to slightly expand (Figure 
8C). We obtain further pictures and reposition, if necessary. When we are 
comfortable with the position, the balloon and stent are fully uncovered and further 
mild inflation is done to allow the proximal part of the balloon (the end close to the 
operator) to inflate (figure 8D). This is done before fully inflating the balloon, thus the 
stent is held in accurate position by the two partially inflated ends of the balloon. An 
angiogram is obtained to confirm the position of the stent and readjustment is done 
as necessary with repeat angiograms. When the position is accurate, the stent is fully 
inflated. During the inflation, steady pressure is maintained by the operator on the 
balloon to ensure the balloon/stent will not travel. Maintaining the extra support wire 
in that position, as well as the steady hand of the operator with gentle push, should 
maintain the stent in its position. If during the inflation, there is any movement of the 
balloon, this can also be readjusted by minimal hand manipulation or alternatively to 
stop the inflation and reposition before the full inflation. Alternatively, the BIB balloon 
allows inflating the center of the stent and the inner balloon first (Figure 4). This also 
may allow partial repositioning of the stent before the full inflation. Once the stent has 
been deployed, repeat angiograms are obtained from the catheter in the LV to 
confirm there is no dissection and the accurate position of the stent. The pressure 
from the LV is compared with the pressure obtained from the arterial end thus 
estimating the residual gradient. Based on the result of the angiogram and the 
residual gradient, if any, mild further dilatation can be done. Achieving a perfect result 
on the first time implanting the stent especially if this is a primary stenting is not 
necessary. Further dilatation after six months to a year can be done. 
 5. Extent of dilatation 
When implanting the stent, the goal is to achieve the largest possible diameter and 
eliminate any gradient to decrease the need for redilation. However the concerns are 
always the possibility of tear or aneurysm formation which may be encountered with 
over dilation We have adopted certain criteria to help achieve safe and effective stent 
implantation. We measure carefully the descending aorta at the level of the 
diaphragm and the proximal transverse arch. The balloon is genrerally chosen to be 
equal to the lesser of the 2 measurements not to exceed 3 times the size of the 
stenotic segment. The balloon is inflated to expand and deploy the stent which may 
not be the full diameter of the balloon or the full pressure. When the stent is 
expanded well we repeat angiography and pressure measurement. If there is 
significant residual gradient and no dissection, repeat balloon dilation using the same 
balloon at the maximum pressure is done. Repeat assessment is performed. If there 
is still significant gradient and no dissection, and we have not exceeded 3 times the 
size of the stenotic segment, a slightly larger balloon may be used. Subsequently 
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flaring of the ends using a lower pressure inflation may be performed if necessary 
though it is not essential. Repeat assessment is done. If there is significant residual 
gradient we would be reluctant to perform further dilation at this point. The patient 
would be brought back to the catheterization laboratory for repeat dilation at a later 
date. We like to wait at least 6 months. Achieving a perfect result is not necessary at 
the time of stent implantation. 
 6. Anticoagulation 
Patients are maintained on aspirin for at least one year after the procedure to avoid 
platelet aggregation. Since this is a high pressure, high flow area it was not felt 
necessary to use warfarin to anti-coagulate the patients.14 
 
Discussion 
Coarctation, if left untreated, poses a significant health risk and up to 90% of the 
patients with isolated coarctation may die before age fifty years of complications of 
coarctation including aortic rupture, intracranial hemorrhages, hypertension, 
endocarditis or heart failure.29,30 With treatment of coarctation and aggressive 
management of this disease, significant improvement in the long-term survival of 
these patients has been seen and is hopefully going to improve with effective and 
successful management. The major burden on the interventional cardiologist is to 
choose the right approach for the specific patient, whether surgery, balloon or stent. 
Each of these modalities have a role for the specific patient. The patient's age weight 
history of surgery influences in great deal the management strategy. Though the use 
of stents to treat coarctation of the aorta has been relatively recent, its use to treat 
peripheral vascular stenosis dates to the mid 1980s18–20 and later in the management 
of other stenotic lesions in congenital heart disease both native and post operative.21–
23 Early animal work in experimental coarctation model21,32 showed promising results. 
However, in another animal model few instances of rupture occurred with redilation.33 
It appeared that in this specific animal model the rupture occurred when the dilation 
was attempted at significantly higher balloon diameter to stenotic lesion ratio. Slowly 
but steadily the use of stents was introduced in the management of coarctation. The 
initial and follow up results have been encouraging with successful gradient 
reduction.12–17,34 Similar to redilation in other lesions,32 redilation of the stented 
coarctation has been possible with further gradient reduction. Few complications 
however have been observed.11,15,16,36. Some appear to be related to using a 
significantly larger balloon to stenotic site ratio or related to balloon choice. 
Recoarctation following balloon angioplasty alone has been seen in 18-31 % of 
patients with native coarctation and in 9-80% of postoperative coarctation,8,9,11 
depending on the age of the patient, the nature of the lesion and size of balloon 
used. Late follow up of angioplasty patients showed that 32% of the patients with 
recurrent coarctation had not had adequate gradient relief (<20 mm. Hg) at the initial 
angioplasty despite adequate balloon / isthmus ratio.8,11 Intravascular stents can 
maintain the patency of a stenotic lesion by eliminating the elastic recoil of the tissue 
and can extend over a relatively long segment of stenosis, thus decreasing the need 
for over expansion or causing intimal tear in these vessels.10,37 Short and 
intermediate term follow up have shown that stented coarctation have good ( if not 
better) gradient relief12–15 and usually the recurrence is attributed to somatic 
growth14,17 or conservative initial dilation (personal experience) to avoid using too 
high balloon to stenosed segment ratio exceeding (3-4 times) in the initial 
implantation. In few patients17 neointimal growth causing mild restenosis was seen in 
growing children who were stented < 6 years old. 
Extension of a stent into the orifices of the branches of the aortic arch is a concern as 
the struts can cause obstruction to the flow in major vessels. In adult size patients, 
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however, the struts of a dilated stent are very small relative to the diameter of the 
subclavian and carotid arteries. Published reports for coarctation as well as in other 
sites14,36 have indicated continued patency and unimpeded flow in these vessels. 
This however must be taken into account during stent implantation. Every effort 
should be made to minimize the extension of the stent across the side branches if 
possible. In those instances where a stent will have to cross the side branches there 
may be a potential advantage for the open cell design though the experience with 
these stents in that position is limited at this time. 
In conclusion, in selected patients with coarctation of the aorta stent implantation 
may be a feasible and improved option to relieve the stenosis. Short and mid-term 
follow-up of these patients have shown encouraging results. Further studies, 
especially addressing long term follow up, are needed. 
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